Literature DB >> 16958674

Alcohol and lipid metabolism.

David W Crabb1, Suthat Liangpunsakul.   

Abstract

Hepatic lipid metabolism is controlled by several master transcription factors, in particular peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and sterol response element binding protein-1 (SREBP-1). Peroxisome proliferator-activated receptor-alpha is a receptor for free fatty acids (FFA), and can activate genes involved in transport, oxidation, and export of FFA. Sterol response element binding protein-1 is a sensor for the level of cholesterol in the liver, and is able to activate genes involved in synthesis of cholesterol and FFA. Chronic ethanol treatment of cells or animals inhibited PPAR-alpha function and activated SREBP. In addition, ethanol inhibited adenosine monophosphate-dependent protein kinase (AMPK). The AMPK controls fatty acid metabolism by inhibiting acetyl-coenzyme A carboxylase, reducing malonyl-coenzyme A, and thereby permitting fatty acid transport into and oxidation in the mitochondrion. Adenosine monophosphate-dependent protein kinase was inhibited in alcohol-treated animals and cells. The mechanisms by which ethanol affects AMPK and the transcription factors are as yet incompletely understood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958674     DOI: 10.1111/j.1440-1746.2006.04582.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  33 in total

Review 1.  Conceptual importance of identifying alcoholic liver disease as a lifestyle disease.

Authors:  Hidekazu Tsukamoto
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

2.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

3.  Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha.

Authors:  Xinqin Kang; Wei Zhong; Jie Liu; Zhenyuan Song; Craig J McClain; Y James Kang; Zhanxiang Zhou
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

4.  Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.

Authors:  Joan Oliva; Samuel W French; Jun Li; Fawzia Bardag-Gorce
Journal:  Exp Mol Pathol       Date:  2012-03-16       Impact factor: 3.362

5.  Ethanol-induced alterations in fatty acid-related lipids in serum and tissues in mice.

Authors:  Zhenwen Zhao; Menggang Yu; David Crabb; Yan Xu; Suthat Liangpunsakul
Journal:  Alcohol Clin Exp Res       Date:  2010-11-08       Impact factor: 3.455

Review 6.  Alcoholic liver disease: mechanisms of injury and targeted treatment.

Authors:  Alexandre Louvet; Philippe Mathurin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

7.  ¹H and ³¹P NMR lipidome of ethanol-induced fatty liver.

Authors:  Harshica Fernando; Shakuntala Kondraganti; Kamlesh K Bhopale; David E Volk; Muniasamy Neerathilingam; Bhupendra S Kaphalia; Bruce A Luxon; Paul J Boor; G A Shakeel Ansari
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

8.  Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.

Authors:  Heng-Hong Li; John B Tyburski; Yi-Wen Wang; Steve Strawn; Bo-Hyun Moon; Bhaskar V S Kallakury; Frank J Gonzalez; Albert J Fornace
Journal:  Alcohol Clin Exp Res       Date:  2014-04-28       Impact factor: 3.455

Review 9.  Autophagy and ethanol-induced liver injury.

Authors:  Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

10.  Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.

Authors:  Tommaso Mello; Simone Polvani; Andrea Galli
Journal:  PPAR Res       Date:  2009-09-14       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.